The global Multiorgan-on-a-Chip market size was valued at US$ 147.7 million in 2023. With growing demand in downstream market, the Multiorgan-on-a-Chip is forecast to a readjusted size of US$ 294.8 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Multiorgan-on-a-Chip market. Multiorgan-on-a-Chip are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Multiorgan-on-a-Chip. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Multiorgan-on-a-Chip market.
Multiorgan-on-a-chip (multi-OoC) devices, by supporting cross-organ communication, allow the study of multiorgan processes and modeling of systemic diseases. Multi-OoC approaches provide new insights that would be lost using single-OoC models.
Multi-organ chip is an advanced biomedical technology, also known as "human organ simulation chip" or "in vitro organ chip". It is used to simulate the structure and function of multiple human organs, and realize the interaction between these organs on the chip. It is the product of the combination of microfluidic chip technology and cell culture technology, aiming to more realistically simulate the complex functions and interrelationships of human organs. Although traditional cell culture and animal experiments are helpful to study the biological characteristics of a single organ, they cannot simulate the interaction between organs and the complex physiological processes in vivo. The emergence of multi-organ chips solves this problem. It can simulate multiple organs on a tiny chip, such as liver, kidney, heart, lung, etc., while simulating blood circulation and signal communication between organs.
Key Features:
The report on Multiorgan-on-a-Chip market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Multiorgan-on-a-Chip market. It may include historical data, market segmentation by Type (e.g., Heart-Liver Two-Organ Model, Heart-Liver-Cancer Three Organ Model), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Multiorgan-on-a-Chip market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Multiorgan-on-a-Chip market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Multiorgan-on-a-Chip industry. This include advancements in Multiorgan-on-a-Chip technology, Multiorgan-on-a-Chip new entrants, Multiorgan-on-a-Chip new investment, and other innovations that are shaping the future of Multiorgan-on-a-Chip.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Multiorgan-on-a-Chip market. It includes factors influencing customer ' purchasing decisions, preferences for Multiorgan-on-a-Chip product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Multiorgan-on-a-Chip market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Multiorgan-on-a-Chip market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Multiorgan-on-a-Chip market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Multiorgan-on-a-Chip industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Multiorgan-on-a-Chip market.
Market Segmentation:
Multiorgan-on-a-Chip market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Heart-Liver Two-Organ Model
Heart-Liver-Cancer Three Organ Model
Neuromuscular Junction (NMJ) Two-Organ Model
Others
Segmentation by application
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CN Bio Innovations
Mimetas
Hesperos
TissUse
Emulate
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Key Questions Addressed in this Report
What is the 10-year outlook for the global Multiorgan-on-a-Chip market?
What factors are driving Multiorgan-on-a-Chip market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Multiorgan-on-a-Chip market opportunities vary by end market size?
How does Multiorgan-on-a-Chip break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Multiorgan-on-a-Chip Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Multiorgan-on-a-Chip by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Multiorgan-on-a-Chip by Country/Region, 2019, 2023 & 2030
2.2 Multiorgan-on-a-Chip Segment by Type
2.2.1 Heart-Liver Two-Organ Model
2.2.2 Heart-Liver-Cancer Three Organ Model
2.2.3 Neuromuscular Junction (NMJ) Two-Organ Model
2.2.4 Others
2.3 Multiorgan-on-a-Chip Sales by Type
2.3.1 Global Multiorgan-on-a-Chip Sales Market Share by Type (2019-2024)
2.3.2 Global Multiorgan-on-a-Chip Revenue and Market Share by Type (2019-2024)
2.3.3 Global Multiorgan-on-a-Chip Sale Price by Type (2019-2024)
2.4 Multiorgan-on-a-Chip Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Academic Research Institutes
2.5 Multiorgan-on-a-Chip Sales by Application
2.5.1 Global Multiorgan-on-a-Chip Sale Market Share by Application (2019-2024)
2.5.2 Global Multiorgan-on-a-Chip Revenue and Market Share by Application (2019-2024)
2.5.3 Global Multiorgan-on-a-Chip Sale Price by Application (2019-2024)
3 Global Multiorgan-on-a-Chip by Company
3.1 Global Multiorgan-on-a-Chip Breakdown Data by Company
3.1.1 Global Multiorgan-on-a-Chip Annual Sales by Company (2019-2024)
3.1.2 Global Multiorgan-on-a-Chip Sales Market Share by Company (2019-2024)
3.2 Global Multiorgan-on-a-Chip Annual Revenue by Company (2019-2024)
3.2.1 Global Multiorgan-on-a-Chip Revenue by Company (2019-2024)
3.2.2 Global Multiorgan-on-a-Chip Revenue Market Share by Company (2019-2024)
3.3 Global Multiorgan-on-a-Chip Sale Price by Company
3.4 Key Manufacturers Multiorgan-on-a-Chip Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Multiorgan-on-a-Chip Product Location Distribution
3.4.2 Players Multiorgan-on-a-Chip Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Multiorgan-on-a-Chip by Geographic Region
4.1 World Historic Multiorgan-on-a-Chip Market Size by Geographic Region (2019-2024)
4.1.1 Global Multiorgan-on-a-Chip Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Multiorgan-on-a-Chip Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Multiorgan-on-a-Chip Market Size by Country/Region (2019-2024)
4.2.1 Global Multiorgan-on-a-Chip Annual Sales by Country/Region (2019-2024)
4.2.2 Global Multiorgan-on-a-Chip Annual Revenue by Country/Region (2019-2024)
4.3 Americas Multiorgan-on-a-Chip Sales Growth
4.4 APAC Multiorgan-on-a-Chip Sales Growth
4.5 Europe Multiorgan-on-a-Chip Sales Growth
4.6 Middle East & Africa Multiorgan-on-a-Chip Sales Growth
5 Americas
5.1 Americas Multiorgan-on-a-Chip Sales by Country
5.1.1 Americas Multiorgan-on-a-Chip Sales by Country (2019-2024)
5.1.2 Americas Multiorgan-on-a-Chip Revenue by Country (2019-2024)
5.2 Americas Multiorgan-on-a-Chip Sales by Type
5.3 Americas Multiorgan-on-a-Chip Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Multiorgan-on-a-Chip Sales by Region
6.1.1 APAC Multiorgan-on-a-Chip Sales by Region (2019-2024)
6.1.2 APAC Multiorgan-on-a-Chip Revenue by Region (2019-2024)
6.2 APAC Multiorgan-on-a-Chip Sales by Type
6.3 APAC Multiorgan-on-a-Chip Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Multiorgan-on-a-Chip by Country
7.1.1 Europe Multiorgan-on-a-Chip Sales by Country (2019-2024)
7.1.2 Europe Multiorgan-on-a-Chip Revenue by Country (2019-2024)
7.2 Europe Multiorgan-on-a-Chip Sales by Type
7.3 Europe Multiorgan-on-a-Chip Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Multiorgan-on-a-Chip by Country
8.1.1 Middle East & Africa Multiorgan-on-a-Chip Sales by Country (2019-2024)
8.1.2 Middle East & Africa Multiorgan-on-a-Chip Revenue by Country (2019-2024)
8.2 Middle East & Africa Multiorgan-on-a-Chip Sales by Type
8.3 Middle East & Africa Multiorgan-on-a-Chip Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Multiorgan-on-a-Chip
10.3 Manufacturing Process Analysis of Multiorgan-on-a-Chip
10.4 Industry Chain Structure of Multiorgan-on-a-Chip
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Multiorgan-on-a-Chip Distributors
11.3 Multiorgan-on-a-Chip Customer
12 World Forecast Review for Multiorgan-on-a-Chip by Geographic Region
12.1 Global Multiorgan-on-a-Chip Market Size Forecast by Region
12.1.1 Global Multiorgan-on-a-Chip Forecast by Region (2025-2030)
12.1.2 Global Multiorgan-on-a-Chip Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Multiorgan-on-a-Chip Forecast by Type
12.7 Global Multiorgan-on-a-Chip Forecast by Application
13 Key Players Analysis
13.1 CN Bio Innovations
13.1.1 CN Bio Innovations Company Information
13.1.2 CN Bio Innovations Multiorgan-on-a-Chip Product Portfolios and Specifications
13.1.3 CN Bio Innovations Multiorgan-on-a-Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 CN Bio Innovations Main Business Overview
13.1.5 CN Bio Innovations Latest Developments
13.2 Mimetas
13.2.1 Mimetas Company Information
13.2.2 Mimetas Multiorgan-on-a-Chip Product Portfolios and Specifications
13.2.3 Mimetas Multiorgan-on-a-Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Mimetas Main Business Overview
13.2.5 Mimetas Latest Developments
13.3 Hesperos
13.3.1 Hesperos Company Information
13.3.2 Hesperos Multiorgan-on-a-Chip Product Portfolios and Specifications
13.3.3 Hesperos Multiorgan-on-a-Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Hesperos Main Business Overview
13.3.5 Hesperos Latest Developments
13.4 TissUse
13.4.1 TissUse Company Information
13.4.2 TissUse Multiorgan-on-a-Chip Product Portfolios and Specifications
13.4.3 TissUse Multiorgan-on-a-Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 TissUse Main Business Overview
13.4.5 TissUse Latest Developments
13.5 Emulate
13.5.1 Emulate Company Information
13.5.2 Emulate Multiorgan-on-a-Chip Product Portfolios and Specifications
13.5.3 Emulate Multiorgan-on-a-Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Emulate Main Business Overview
13.5.5 Emulate Latest Developments
13.6 Micronit Microtechnologies B.V.
13.6.1 Micronit Microtechnologies B.V. Company Information
13.6.2 Micronit Microtechnologies B.V. Multiorgan-on-a-Chip Product Portfolios and Specifications
13.6.3 Micronit Microtechnologies B.V. Multiorgan-on-a-Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Micronit Microtechnologies B.V. Main Business Overview
13.6.5 Micronit Microtechnologies B.V. Latest Developments
13.7 Kirkstall
13.7.1 Kirkstall Company Information
13.7.2 Kirkstall Multiorgan-on-a-Chip Product Portfolios and Specifications
13.7.3 Kirkstall Multiorgan-on-a-Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Kirkstall Main Business Overview
13.7.5 Kirkstall Latest Developments
13.8 Cherry Biotech SAS
13.8.1 Cherry Biotech SAS Company Information
13.8.2 Cherry Biotech SAS Multiorgan-on-a-Chip Product Portfolios and Specifications
13.8.3 Cherry Biotech SAS Multiorgan-on-a-Chip Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Cherry Biotech SAS Main Business Overview
13.8.5 Cherry Biotech SAS Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
